25 XP   0   0   10

Integragen
Buy, Hold or Sell?

Let's analyse Integragen together

PenkeI guess you are interested in Integragen. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Integragen. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Integragen

I send you an email if I find something interesting about Integragen.

Quick analysis of Integragen (30 sec.)










What can you expect buying and holding a share of Integragen? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.33
Expected worth in 1 year
€0.33
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
€0.00
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
€0.65
Expected price per share
€0.63 - €0.93
How sure are you?
50%

1. Valuation of Integragen (5 min.)




Live pricePrice per Share (EOD)

€0.65

2. Growth of Integragen (5 min.)




Is Integragen growing?

Current yearPrevious yearGrowGrow %
How rich?$2.3m$2.3m0.000.0%

How much money is Integragen making?

Current yearPrevious yearGrowGrow %
Making money0.00-$3.7k$3.7k?
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Integragen (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#814 / 1016

Most Revenue
#282 / 1016

Most Profit
#171 / 1016

Most Efficient
#378 / 1016

What can you expect buying and holding a share of Integragen? (5 min.)

Welcome investor! Integragen's management wants to use your money to grow the business. In return you get a share of Integragen.

What can you expect buying and holding a share of Integragen?

First you should know what it really means to hold a share of Integragen. And how you can make/lose money.

Speculation

The Price per Share of Integragen is €0.65. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Integragen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Integragen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.33. Based on the TTM, the Book Value Change Per Share is €0.00 per quarter. Based on the YOY, the Book Value Change Per Share is €0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Integragen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.000.0%0.000.0%0.00-0.1%-0.02-3.2%-0.11-17.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.000.4%-0.02-2.9%0.023.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.000.4%-0.02-2.9%0.023.7%
Usd Price Per Share0.95-0.95-1.29-1.34-2.46-
Price to Earnings Ratio0.00-0.00--2,290.32--371.97--195.30-
Price-to-Total Gains Ratio551.85-232.57-99.13-
Price to Book Ratio2.70-2.70-3.65-3.73-6.27-
Price-to-Total Gains Ratio551.85-232.57-99.13-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.69199
Number of shares1445
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.02
Usd Total Gains Per Share0.00-0.02
Gains per Quarter (1445 shares)0.00-27.49
Gains per Year (1445 shares)0.00-109.96
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
100-100-110-120
200-100-220-230
300-100-330-340
400-100-440-450
500-100-550-560
600-100-660-670
700-100-770-780
800-100-880-890
900-100-990-1000
1000-100-1100-1110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.00.01.00.0%1.01.01.033.3%1.03.01.020.0%1.08.01.010.0%1.010.01.08.3%
Book Value Change Per Share0.00.01.00.0%2.00.01.066.7%2.02.01.040.0%4.05.01.040.0%5.06.01.041.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.012.00.0%
Total Gains per Share0.00.01.00.0%2.00.01.066.7%2.02.01.040.0%4.05.01.040.0%5.06.01.041.7%

Fundamentals of Integragen

About Integragen

IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was incorporated in 2000 and is headquartered in Évry, France. IntegraGen SA operates as a subsidiary of OncoDNA SA.

Fundamental data was last updated by Penke on 2024-04-09 12:24:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.

1.1. Profitability of Integragen.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Integragen earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Integragen to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Integragen:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY0.0%+0.0%
TTM-5Y-1.5%+1.5%
5Y-1.5%10Y-11.0%+9.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY0.0%-279.3%+279.3%
5Y-1.5%-438.4%+436.9%
10Y-11.0%-605.5%+594.5%
1.1.2. Return on Assets

Shows how efficient Integragen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Integragen to the Biotechnology industry mean.
  • 0.0% Return on Assets means that Integragen generated €0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Integragen:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY0.0%+0.0%
TTM-5Y-1.7%+1.7%
5Y-1.7%10Y-8.3%+6.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM--12.9%+12.9%
YOY0.0%-11.8%+11.8%
5Y-1.7%-14.1%+12.4%
10Y-8.3%-16.0%+7.7%
1.1.3. Return on Equity

Shows how efficient Integragen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Integragen to the Biotechnology industry mean.
  • 0.0% Return on Equity means Integragen generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Integragen:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.2%+0.2%
TTM-5Y-5.6%+5.6%
5Y-5.6%10Y-30.0%+24.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY-0.2%-15.1%+14.9%
5Y-5.6%-19.9%+14.3%
10Y-30.0%-20.9%-9.1%

1.2. Operating Efficiency of Integragen.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Integragen is operating .

  • Measures how much profit Integragen makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Integragen to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Integragen:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.8%+0.8%
TTM-5Y-1.4%+1.4%
5Y-1.4%10Y-13.3%+11.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY-0.8%-288.4%+287.6%
5Y-1.4%-477.4%+476.0%
10Y-13.3%-625.6%+612.3%
1.2.2. Operating Ratio

Measures how efficient Integragen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Integragen:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.008-1.008
TTM-5Y0.814-0.814
5Y0.81410Y1.017-0.203
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY1.0083.783-2.775
5Y0.8145.679-4.865
10Y1.0177.894-6.877

1.3. Liquidity of Integragen.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Integragen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.00 means the company has €0.00 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Integragen:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.526-1.526
TTM-5Y1.448-1.448
5Y1.44810Y1.713-0.264
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.914-3.914
TTM-4.220-4.220
YOY1.5265.388-3.862
5Y1.4486.045-4.597
10Y1.7136.406-4.693
1.3.2. Quick Ratio

Measures if Integragen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Integragen to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off €0.00 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Integragen:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.791-1.791
TTM-5Y1.831-1.831
5Y1.83110Y1.976-0.144
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.572-3.572
TTM-3.998-3.998
YOY1.7915.390-3.599
5Y1.8315.969-4.138
10Y1.9766.287-4.311

1.4. Solvency of Integragen.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Integragen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Integragen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.76 means that Integragen assets are financed with 75.6% credit (debt) and the remaining percentage (100% - 75.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Integragen:

  • The MRQ is 0.756. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.756. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.756TTM0.7560.000
TTM0.756YOY0.7560.000
TTM0.7565Y0.733+0.023
5Y0.73310Y0.697+0.037
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7560.336+0.420
TTM0.7560.334+0.422
YOY0.7560.269+0.487
5Y0.7330.366+0.367
10Y0.6970.390+0.307
1.4.2. Debt to Equity Ratio

Measures if Integragen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Integragen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 310.0% means that company has €3.10 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Integragen:

  • The MRQ is 3.100. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.100. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.100TTM3.1000.000
TTM3.100YOY3.1000.000
TTM3.1005Y2.869+0.231
5Y2.86910Y2.591+0.278
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1000.382+2.718
TTM3.1000.396+2.704
YOY3.1000.335+2.765
5Y2.8690.434+2.435
10Y2.5910.465+2.126

2. Market Valuation of Integragen

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Integragen generates.

  • Above 15 is considered overpriced but always compare Integragen to the Biotechnology industry mean.
  • A PE ratio of 0.00 means the investor is paying €0.00 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Integragen:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-2,290.323+2,290.323
TTM-5Y-371.971+371.971
5Y-371.97110Y-195.297-176.674
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--2.569+2.569
TTM--2.664+2.664
YOY-2,290.323-4.120-2,286.203
5Y-371.971-6.258-365.713
10Y-195.297-6.171-189.126
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Integragen:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY19.925-19.925
TTM-5Y13.577-13.577
5Y13.57710Y6.788+6.788
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.246+3.246
TTM--3.488+3.488
YOY19.925-5.620+25.545
5Y13.577-8.315+21.892
10Y6.788-8.826+15.614
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Integragen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.70 means the investor is paying €2.70 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Integragen:

  • The EOD is 1.961. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.697. Based on the equity, the company is underpriced. +1
  • The TTM is 2.697. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.961MRQ2.697-0.736
MRQ2.697TTM2.6970.000
TTM2.697YOY3.650-0.953
TTM2.6975Y3.731-1.035
5Y3.73110Y6.273-2.542
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.9611.851+0.110
MRQ2.6972.090+0.607
TTM2.6972.095+0.602
YOY3.6502.844+0.806
5Y3.7313.466+0.265
10Y6.2733.815+2.458
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Integragen compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%0.002-100%-0.0180%0.023-100%
Book Value Per Share--0.3320.3320%0.3320%0.339-2%0.391-15%
Current Ratio----0%1.526-100%1.448-100%1.713-100%
Debt To Asset Ratio--0.7560.7560%0.7560%0.733+3%0.697+9%
Debt To Equity Ratio--3.1003.1000%3.1000%2.869+8%2.591+20%
Dividend Per Share----0%-0%-0%-0%
Eps----0%-0.0010%-0.0200%-0.1040%
Gross Profit Margin----0%1.000-100%0.800-100%0.900-100%
Market Cap4314797.500-38%5934506.1005934506.1000%8032161.500-26%8330193.400-29%15370293.900-61%
Net Profit Margin----0%0.0000%-0.0150%-0.1100%
Operating Margin----0%-0.0080%-0.0140%-0.1330%
Operating Ratio----0%1.008-100%0.814-100%1.017-100%
Pb Ratio1.961-38%2.6972.6970%3.650-26%3.731-28%6.273-57%
Pe Ratio----0%-2290.3230%-371.9710%-195.2970%
Price Per Share0.650-38%0.8940.8940%1.210-26%1.254-29%2.315-61%
Price To Free Cash Flow Ratio----0%19.925-100%13.577-100%6.788-100%
Quick Ratio----0%1.791-100%1.831-100%1.976-100%
Return On Assets----0%0.0000%-0.0170%-0.0830%
Return On Equity----0%-0.0020%-0.0560%-0.3000%
Total Gains Per Share----0%0.002-100%-0.0180%0.023-100%
Usd Book Value--2342712.9822342712.9820%2342712.9820%2399166.804-2%2764741.395-15%
Usd Book Value Change Per Share----0%0.002-100%-0.0190%0.024-100%
Usd Book Value Per Share--0.3530.3530%0.3530%0.361-2%0.416-15%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps----0%-0.0010%-0.0210%-0.1100%
Usd Free Cash Flow----0%429153.035-100%269892.708-100%134946.354-100%
Usd Market Cap4593533.419-38%6317875.1946317875.1940%8551039.133-26%8868323.894-29%16363214.886-61%
Usd Price Per Share0.692-38%0.9520.9520%1.288-26%1.335-29%2.465-61%
Usd Profit----0%-3733.5520%-137963.0040%-732222.9370%
Usd Revenue--12510114.60012510114.6000%14017332.696-11%11391476.356+10%8975919.822+39%
Usd Total Gains Per Share----0%0.002-100%-0.0190%0.024-100%
 EOD+2 -3MRQTTM+0 -0YOY+4 -125Y+5 -1210Y+5 -16

3.2. Fundamental Score

Let's check the fundamental score of Integragen based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Book Ratio (EOD)Between0-11.961
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than10.756
Debt to Equity Ratio (MRQ)Less than13.100
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total1/9 (11.1%)

3.3. Technical Score

Let's check the technical score of Integragen based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.317
Ma 20Greater thanMa 500.700
Ma 50Greater thanMa 1000.741
Ma 100Greater thanMa 2000.801
OpenGreater thanClose0.660
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Current Assets  0190190-7182-18164-3,064-2,900
Operating Income  -339167-172143-30-80-11011,86111,751



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
 As reported
Total Liabilities 0
Total Stockholder Equity+ 0
Total Assets = 0

Assets

Total Current Assets
Cash And Cash Equivalents 2,900
Other Current Assets -2,900
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities
Total Current Liabilities  (as reported)0
Total Current Liabilities  (calculated)0
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Cash and Short Term Investments 2,900
Net Debt -2,900



Balance Sheet

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
> Total Assets 
3,577
4,187
8,180
6,967
7,854
5,784
9,170
8,620
7,590
8,649
8,583
6,748
8,822
9,604
9,023
0
09,0239,6048,8226,7488,5838,6497,5908,6209,1705,7847,8546,9678,1804,1873,577
   > Total Current Assets 
3,459
4,085
7,743
6,216
7,169
5,305
8,290
7,349
6,087
7,911
7,322
5,691
7,948
8,972
8,555
0
08,5558,9727,9485,6917,3227,9116,0877,3498,2905,3057,1696,2167,7434,0853,459
       Cash And Cash Equivalents 
50
437
220
634
322
445
683
1,477
549
1,343
735
1,199
1,019
2,936
2,460
2,900
2,9002,4602,9361,0191,1997351,3435491,47768344532263422043750
       Short-term Investments 
699
991
5,797
4,015
4,553
2,389
4,554
3,541
2,177
2,790
3,271
1,608
4,105
1,844
2,047
0
02,0471,8444,1051,6083,2712,7902,1773,5414,5542,3894,5534,0155,797991699
       Net Receivables 
2,113
1,846
1,498
1,239
1,990
2,114
2,568
1,928
2,763
3,260
2,718
2,594
2,396
3,666
3,487
0
03,4873,6662,3962,5942,7183,2602,7631,9282,5682,1141,9901,2391,4981,8462,113
       Inventory 
216
366
93
180
198
234
340
268
378
360
380
290
238
343
397
0
039734323829038036037826834023419818093366216
   > Long-term Assets 
118
103
437
751
685
479
880
1,271
1,502
738
1,251
1,057
874
633
468
0
04686338741,0571,2517381,5021,271880479685751437103118
       Property Plant Equipment 
69
56
59
213
211
162
240
345
512
436
913
827
572
415
277
0
0277415572827913436512345240162211213595669
       Long Term Investments 
0
0
0
0
0
127
328
344
323
302
217
0
0
0
0
0
0000021730232334432812700000
       Intangible Assets 
5
0
0
0
0
7
4
2
0
0
0
0
0
0
0
0
0000000024700005
       Other Assets 
0
9
0
155
108
6
323
584
689
0
9
0
0
0
0
0
00000906895843236108155090
> Total Liabilities 
2,095
2,907
3,047
3,875
4,617
5,092
5,408
5,687
6,307
4,719
5,789
4,239
6,650
7,418
6,823
0
06,8237,4186,6504,2395,7894,7196,3075,6875,4085,0924,6173,8753,0472,9072,095
   > Total Current Liabilities 
1,696
2,442
2,282
2,327
3,130
3,394
3,288
3,484
4,081
4,129
3,967
2,821
3,932
5,347
5,607
0
05,6075,3473,9322,8213,9674,1294,0813,4843,2883,3943,1302,3272,2822,4421,696
       Short-term Debt 
699
991
5,797
4,015
0
2,389
4,554
3,541
2,177
2,790
3,271
241
63
320
548
0
0548320632413,2712,7902,1773,5414,5542,38904,0155,797991699
       Short Long Term Debt 
0
0
0
0
0
1,655
532
1,593
1,493
263
269
241
2,012
1,953
508
0
05081,9532,0122412692631,4931,5935321,65500000
       Accounts payable 
409
641
356
637
1,171
1,387
1,200
1,203
1,650
1,125
1,546
701
901
1,771
1,605
0
01,6051,7719017011,5461,1251,6501,2031,2001,3871,171637356641409
       Other Current Liabilities 
529
664
1,925
1,538
1,964
2,008
2,232
2,306
2,461
3,004
2,421
50
1,877
2,044
1,639
0
01,6392,0441,877502,4213,0042,4612,3062,2322,0081,9641,5381,925664529
   > Long-term Liabilities 
400
465
765
1,548
1,486
1,697
2,120
2,203
2,226
590
1,822
1,418
2,718
2,071
1,215
0
01,2152,0712,7181,4181,8225902,2262,2032,1201,6971,4861,548765465400
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
300
241
2,015
1,953
0
0
001,9532,0152413000000000000
       Other Liabilities 
790
1,146
42
155
120
11
323
586
703
17
80
132
54
8
0
0
00854132801770358632311120155421,146790
> Total Stockholder Equity
1,482
1,280
5,133
3,093
3,237
692
3,762
2,933
1,282
3,930
2,794
2,509
2,172
2,186
2,201
0
02,2012,1862,1722,5092,7943,9301,2822,9333,7626923,2373,0935,1331,2801,482
   Common Stock
2,647
2,971
3,771
3,771
4,115
4,115
4,970
5,070
5,070
6,544
6,552
6,564
6,704
3,364
3,364
0
03,3643,3646,7046,5646,5526,5445,0705,0704,9704,1154,1153,7713,7712,9712,647
   Retained Earnings Total Equity0000000000000000
   Accumulated Other Comprehensive Income 
0
-362
-386
-414
0
-487
-581
-657
-615
-835
-971
-1,222
25
0
18
0
018025-1,222-971-835-615-657-581-4870-414-386-3620
   Capital Surplus 
0
0
0
0
0
0
0
0
36,184
38,220
38,114
5,089
5,084
0
0
0
0005,0845,08938,11438,22036,18400000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
39,063
39,194
5,211
5,084
0
-18
0
0-1805,0845,21139,19439,063000000000



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue11,751
Cost of Revenue-0
Gross Profit11,75111,751
 
Operating Income (+$)
Gross Profit11,751
Operating Expense-0
Operating Income11,75111,751
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense00
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income11,751
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)011,751
EBIT - interestExpense = 0
0
0
Interest Expense0
Earnings Before Interest and Taxes (EBIT)00
Earnings Before Interest and Taxes (EBITDA)11,751
 
After tax Income (+$)
Income Before Tax0
Tax Provision-0
Net Income From Continuing Ops00
Net Income0
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net00
 

Technical Analysis of Integragen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Integragen. The general trend of Integragen is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Integragen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Integragen.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.758 < 0.86 < 0.93.

The bearish price targets are: 0.63 > 0.63.

Tweet this
Integragen Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Integragen. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Integragen Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Integragen. The current macd is -0.01602845.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Integragen price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Integragen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Integragen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Integragen Daily Moving Average Convergence/Divergence (MACD) ChartIntegragen Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Integragen. The current adx is 22.89.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Integragen shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Integragen Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Integragen. The current sar is 0.8559.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Integragen Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Integragen. The current rsi is 39.32. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Integragen Daily Relative Strength Index (RSI) ChartIntegragen Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Integragen. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Integragen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Integragen Daily Stochastic Oscillator ChartIntegragen Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Integragen. The current cci is -152.52939568.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Integragen Daily Commodity Channel Index (CCI) ChartIntegragen Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Integragen. The current cmo is -28.84523745.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Integragen Daily Chande Momentum Oscillator (CMO) ChartIntegragen Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Integragen. The current willr is -91.30434783.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Integragen Daily Williams %R ChartIntegragen Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Integragen.

Integragen Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Integragen. The current atr is 0.03841022.

Integragen Daily Average True Range (ATR) ChartIntegragen Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Integragen. The current obv is 178,026.

Integragen Daily On-Balance Volume (OBV) ChartIntegragen Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Integragen. The current mfi is 61.14.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Integragen Daily Money Flow Index (MFI) ChartIntegragen Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Integragen.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Integragen Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Integragen based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.317
Ma 20Greater thanMa 500.700
Ma 50Greater thanMa 1000.741
Ma 100Greater thanMa 2000.801
OpenGreater thanClose0.660
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Integragen with someone you think should read this too:
  • Are you bullish or bearish on Integragen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Integragen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Integragen

I send you an email if I find something interesting about Integragen.


Comments

How you think about this?

Leave a comment

Stay informed about Integragen.

Receive notifications about Integragen in your mailbox!